Aligning Pediatric Patient Needs With Drug Development Success

A recent webinar presented by Adare Pharma Solutions examined concerns critical to the development of therapies for pediatric populations. Following the presentation, audience members had the opportunity to engage in a Q&A session with Srinivasan Shanmugam, Ph.D., Executive Director of Pharmaceutical Sciences at Adare.

Topics discussed in this bonus session included key causes of low pediatric patient compliance, regulations impacting pediatric clinical trial access, the potential for sensing technology feedback in pediatric applications, and excipients within pediatric formulations.